
Solid Underwriting Results Continued in 2025 for Leadenhall Backed Nectaris Re: Am Best
Companies Mentioned
Why It Matters
Consistent ‘A’ rating and steady profits signal robust risk management, reassuring investors in the ILS space and encouraging further capital inflow into reinsurance strategies. The anticipated open‑market growth expands Nectaris Re’s market share, potentially enhancing returns for Leadenhall’s fund participants.
Key Takeaways
- •Nectaris Re affirmed ‘A’ rating by AM Best for third year
- •Underwriting profit stayed around $13 million in 2023‑2024
- •Open‑market reinsurance volume expected to grow in 2026
- •Higher interest rates boosted investment income in 2025
- •Leadenhall’s ILS funds provide fully‑collateralized backing
Pulse Analysis
The reinsurance industry has increasingly turned to insurance‑linked securities (ILS) to diversify risk and access capital outside traditional markets. Nectaris Re, launched in 2021 under Leadenhall Capital Partners, serves as a rated balance‑sheet platform that channels ILS fund capital into underwriting opportunities. AM Best’s reaffirmation of an ‘A’ rating underscores the platform’s solid governance, capital adequacy, and the effectiveness of its mutual cooperation agreement, which grants Leadenhall’s funds a fully‑collateralized conduit to write reinsurance business.
Performance data shows Nectaris Re delivering consistent underwriting profits of about $13 million in both 2023 and 2024, a notable achievement given the volatile catastrophe landscape. The firm also benefited from a higher interest‑rate environment in 2025, which lifted investment income without compromising its underwriting focus. Moreover, the company is expanding beyond legacy sources such as MS Amlin’s Lloyd’s syndicate, tapping open‑market deals that are projected to increase in 2026. This diversification reduces concentration risk and positions Nectaris Re to capture a broader set of premium opportunities.
For investors, the stable rating and flat profit trajectory translate into predictable risk‑adjusted returns, especially as Leadenhall’s ILS funds continue to provide fully‑collateralized backing. The anticipated growth in open‑market volume could enhance yield potential and attract new capital, reinforcing the platform’s role as a bridge between capital markets and traditional reinsurance. As the industry seeks resilient structures amid climate uncertainty, Nectaris Re’s model offers a compelling template for blending rated balance‑sheet strength with alternative capital sources.
Solid underwriting results continued in 2025 for Leadenhall backed Nectaris Re: Am Best
Comments
Want to join the conversation?
Loading comments...